References
- World Health Organization. Immunization; 2019. Available from: https://www.who.int/news-room/facts-in-pictures/detail/immunization
- Whitney CG, Zhou F, Singleton J, et al. Benefits from immunization during the vaccines for children program era – United States, 1994–2013. MMWR Morb Mortal Wkly Rep. 2014;63(16):352–355.
- Li X, Mukandavire C, Cucunubá ZM, et al. Estimating the health impact of vaccination against ten pathogens in 98 low-income and Middle-income countries from 2000 to 2030: a modelling study. Lancet. 2021;397(10272):398–408.
- Modlin JF, Schaffner W, Orenstein W, et al. Triumphs of immunization. J Infect Dis. 2021;224(12 Suppl 2):S307–S308.
- Centers for Disease Control and Prevention. Recommended child and adolescent immunization schedule for ages 18 years or younger United States 2019; 2019 [cited 2021 Nov 19]. Available from: https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf
- Elaine Miller APW. General best practice guidance for immunization; 2021. Available from: https://www.cdc.gov/vaccines/pubs/pinkbook/genrec.html
- Klein NP. Licensed pertussis vaccines in the United States. History and current state. Hum Vaccin Immunother. 2014;10(9):2684–2690.
- Food and Drug Administration. PEDIARIX [Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine], suspension for intramuscular injection. GlaxoSmithKline Biologicals; 2019 [updated 2019 Oct; cited 2022 Apr 29]. Available from: https://www.fda.gov/media/79830/download
- Food and Drug Administration. Pentacel (diphtheria and tetanus toxoids and acellular pertussis adsorbed, inactivated poliovirus and Haemophilus b conjugate (tetanus toxoid conjugate). Vaccine: Sanofi Pasteur Limited; 2019 [updated 2019 Dec; cited 2022 Apr 29]. Available from: https://www.fda.gov/media/146048/download
- Food and Drug Administration. VAXELIS (diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus b conjugate and hepatitis B vaccine). MSP Vaccine Company; 2020. [updated 2020 Oct; cited 2022 Jan 24]. Available from: https://www.fda.gov/vaccines-blood-biologics/vaxelis
- Oliver SE, Moore KL. Licensure of a diphtheria and tetanus toxoids and acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate, and hepatitis B vaccine, and guidance for use in infants. MMWR Morb Mortal Wkly Rep. 2020;69(5):136–139.
- Kurosky SK, Davis KL, Krishnarajah G. Effect of combination vaccines on completion and compliance of childhood vaccinations in the United States. Hum Vaccin Immunother. 2017;13(11):2494–2502.
- Marshall GS, Happe LE, Lunacsek OE, et al. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J. 2007;26(6):496–500.
- Centers for Disease Control and Prevention. Timing and spacing of immunobiologics; 2021 [cited 2021 Dec 20]. Available from: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/timing.html#simultaneous
- Happe LE, Lunacsek OE, Kruzikas DT, et al. Impact of a pentavalent combination vaccine on immunization timeliness in a state medicaid population. Pediatr Infect Dis J. 2009;28(2):98–101.
- Icardi G, Orsi A, Vitali Rosati G, et al. Preferences of healthcare professionals regarding hexavalent pediatric vaccines in Italy: a survey of attitudes and expectations. J Prev Med Hyg. 2020;61(3):E424–E444.
- De Coster I, Fournie X, Faure C, et al. Assessment of preparation time with fully-liquid versus non-fully liquid paediatric hexavalent vaccines. A time and motion study. Vaccine. 2015;33(32):3976–3982.
- Cuesta Esteve I, Fernandez Fernandez P, Lopez Palacios S, et al. Health care professionals' preference for a fully liquid, ready-to-use hexavalent vaccine in Spain. Prev Med Rep. 2021;22:101376.
- Lloyd AJ, Nafees B, Ziani E, et al. What are the preferences of health care professionals in Germany regarding fully liquid, ready-to-use hexavalent pediatric vaccine versus hexavalent pediatric vaccine that needs reconstitution? Patient Prefer Adherence. 2015;9:1517–1524.
- Kaiser Family Foundation. Professionally active primary care physicians by field; 2019. Available from: https://www.kff.org/other/state-indicator/primary-care-physicians-by-field/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D
- American Board of Pediatrics. Pediatric physicians workforce data book 2017–2018. Available from: https://www.abp.org/sites/abp/files/pdf/pediatricphysiciansworkforcedatabook2017-2018.pdf
- Agency for Healthcare Research and Quality. The distribution of the U.S. primary care workforce. Primary care workforce facts and stats [updated 2018 Jul; cited 2021 Nov 19]. Available from: https://www.ahrq.gov/research/findings/factsheets/primary/pcwork3/index.html
- ChoiceMetrics. Ngene 1.2 user manual & reference guide; 2018. Available from: http://www.choice-metrics.com/NgeneManual120.pdf
- Orme B. Sample size issues for conjoint analysis. 4th ed. Madison (WI): Research Publishers LLC; 2010. (Getting started with conjoint analysis: strategies for product design and pricing research).
- Gould W, Pitblado J, Sribney W. Maximum likelihood estimation with Stata. 3rd ed. College Station (TX): Stata Press; 2006.
- Black J, Hashimzade N, Myles G. A dictionary of economics. 3rd ed. Oxford (UK): Oxford University Press; 2009.
- Bakhache P, Virey B, Bienenfeld C. Knowledge and practices regarding infant vaccination: results of a survey of French physicians. Eur J Pediatr. 2019;178(4):533–540.
- Pellissier JM, Coplan PM, Jackson LA, et al. The effect of additional shots on the vaccine administration process: results of a time-motion study in 2 settings. Am J Manag Care. 2000;6(9):1038–1044.